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Abstract
Purpose To establish optimal management of patients with an umbilical hernia complicated by liver cirrhosis and ascites.
Methods Patients with an umbilical hernia and liver cirrhosis and ascites were randomly assigned to receive either elective repair
or conservative treatment. The primary endpoint was overall morbidity related to the umbilical hernia or its treatment after 24
months of follow-up. Secondary endpoints included the severity of these hernia-related complications, quality of life, and
cumulative hernia recurrence rate.
Results Thirty-four patients were included in the study. Sixteen patients were randomly assigned to elective repair and 18 to
conservative treatment. After 24months, 8 patients (50%) assigned to elective repair compared to 14 patients (77.8%) assigned to
conservative treatment had a complication related to the umbilical hernia or its repair. A recurrent hernia was reported in 16.7% of
patients who underwent repair. For the secondary endpoint, quality of life through the physical (PCS) and mental component
score (MCS) showed no significant differences between groups at 12 months of follow-up (mean difference PCS 11.95, 95% CI
− 0.87 to 24.77; MCS 10.04, 95% CI − 2.78 to 22.86).
Conclusion This trial could not show a relevant difference in overall morbidity after 24 months of follow-up in favor of elective
umbilical hernia repair, because of the limited number of patients included. However, elective repair of umbilical hernia in
patients with liver cirrhosis and ascites appears feasible, nudging its implementation into daily practice further, particularly for
patients experiencing complaints.
Trial registration Clinicaltrials.gov, NCT01421550, on 23 August 2011.
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Introduction
Umbilical hernias are common in patients with liver cirrhosis
and ascites, with an incidence of up to 20% [1, 2]. The pres-
ence of ascites increases the risk of developing an umbilical
hernia, due to increased abdominal pressure. Weakening of
the abdominal wall, muscle wasting when nutritional status
is poor, and dilatation of the umbilical vein—enlarging the
pre-existent fascial opening—in patients with portal hyperten-
sion are additional contributing factors [3, 4].
Currently, there are no guidelines for themanagement of an
umbilical hernia and its timing of surgical repair in patients
with liver cirrhosis and ascites. Traditional surgical dogma
dictates not to perform umbilical hernia repair under these
circumstances, because of the presumed high surgical risks
and high recurrence rates after surgery [5, 6]. Additionally,
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portal hypertension is common in cirrhotic patients with asci-
tes, and this requires special caution because a patent umbili-
cal vein is often present. A reopened umbilical vein can be an
important outflow for the portal circulation in patients with
severe portal hypertension. In these patients, elective repair
without liver transplantation has been reported to result in
acute portal vein thrombosis due to ligation of the umbilical
vein during hernia repair, which in turn causes subsequent
liver failure, necessitating emergency liver transplantation [7].
However, refraining from umbilical hernia repair under
these circumstances can also result in serious complications:
incarceration or evisceration of the bowel could occur, follow-
ed by necrosis of the overlying skin, necessitating emergency
surgery [4, 7, 8]. Even after liver transplantation, incarceration
and strangulation can still occur in untreated umbilical hernias
[8]. Moreover, several studies have shown that emergency
surgery is generally associated with even higher risks of mor-
bidity and mortality compared to elective surgery, particularly
in patients with liver cirrhosis [6, 8–12]. This underlines that
emergency surgery in this group of frail patients should be
avoided and that elective umbilical hernia repair might be
the most optimal management [13, 14]. Concordingly, several
retrospective and prospective series have shown good results
with elective umbilical hernia repair for patients with liver
cirrhosis [8, 12, 14]. However, no randomized controlled trial
on this matter has been performed. The aim of this study was
to compare conservative treatment with the elective repair of
umbilical hernia in patients with liver cirrhosis and ascites.We
hypothesized that elective repair of the umbilical hernia would
result in a significant reduction of the overall complication
rate and a better quality of life compared to conservative
treatment.
Methods
Study design
The CRUCIAL trial is a randomized controlled trial conduct-
ed in two centers. Patients with liver cirrhosis and ascites older
than 18 years and a primary umbilical hernia were included in
the study. The presence of ascites had to be proven on imaging
or had to have been drained previously. Patients were random-
ized into one of two groups: patients in group 1 would under-
go elective surgical repair and those in group 2 would receive
conservative treatment. Irrespective of the randomization
group, in the case of liver transplantation, patients would re-
ceive umbilical hernia repair simultaneously if the repair had
not yet been performed. Excluded from participation were
patients with a recurrent umbilical hernia following a midline
laparotomy in the medical history, patients who presented
with American Society of Anesthesiology (ASA) score IV
or above, patients with incarcerated hernia requiring
emergency repair, patients with a patent umbilical vein of
more than 5 mm in diameter, and patients with an expected
time to liver transplantation of less than 3 months.
The study protocol was approved by the institutional med-
ical ethical review board of the Erasmus University Medical
Center, Rotterdam, before the start of inclusion. All patients
gave written informed consent. An independent data and safe-
ty monitoring board was constituted before the start of the
trial, consisting of two independent surgeons and one biomed-
ical statistician. All serious adverse events were reported to the
institutional review board of the Erasmus University Medical
Center. The progress of the trial and adverse events were re-
ported to the safety monitoring board.
Randomization and masking
Patients were randomly allocated to either conservative treat-
ment or elective repair by means of sealed, numbered enve-
lopes that were opened in sequence. The randomization pro-
cedure was stratified for the participating center and for the
model of end-stage liver disease (MELD) score ≤ 15 and > 15
and took place after collection of baseline information.
Blinding for allocation did not take place for the participants,
evaluators, and surgeons.
Procedures
All repairs (elective or during liver transplantation) took place
using a (separate) infra-umbilical incision, dissection
(avoiding resection) of the hernia sac, and restoration of the
sac and its contents into the abdominal cavity. Intra-operative
resection of the sac had to be recorded on the patient’s oper-
ation report. As mesh repair has been proven to reduce recur-
rence rates [15], non-absorbable monofilament sutures were
combined with a flat circular polypropylene mesh placed in
the onlay position or in the pre-peritoneal plane. The overlap
of the mesh had to be at least 3 cm in each direction. Closure
of the subcutaneous tissue and skin were performed at the
discretion of the surgeon.
The preferred method of anesthesia was general anesthesia,
allowing for local or spinal anesthesia in the case of contra-
indications for general anesthesia. Antibiotic prophylaxis was
administered 10 to 30 min preoperatively.
Patients were followed up at the outpatient clinic at 2 to 3
weeks, 3 months, 12 months, and 24 months after surgery.
During these visits, patients underwent physical examination,
and at the 12-month visit, they underwent abdominal ultraso-
nography to diagnose hernia recurrence. Quality of life mea-
surements took place at baseline, 3, 6, 12, and 24 months
through the Short Form-36 (SF-36) and the EuroQoL-5D
(EQ-5D) questionnaire. The pain was evaluated through the
visual analogue scale (VAS), anchored by “no pain” (score of
0), and “worst imaginable pain” (score of 100) on a 100-mm
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scale. To avoid clustering of scores around a preferred numer-
ic value, numbers of verbal descriptors at intermediate points
were not provided.
Outcomes
The primary outcome consisted of the hernia (and when ap-
plicable, its surgery)-related complications during 2 years of
follow-up. Superficial or deep surgical site infection (SSI)
[16], seroma, pneumonia, hematoma, urinary tract infection,
and non-closure or delayed closure of the surgical wound at 4
weeks were considered minor complications. Major compli-
cations were mortality, evisceration, incarceration, necrosis of
the overlying skin of the umbilical hernia, postoperative (> 2
weeks) leakage of ascites, liver failure, bacterial peritonitis,
decompensated ascites, organ space SSI, or unexpected inten-
sive care unit (ICU) admission related to the hernia or its
repair.
These hernia-related complications were assessed for se-
verity through the National Surgical Complication Registry
(“Landelijke Heelkundige Complicatie Registratie” (LHCR))
grading tool (Table 1), scoring the maximal observed grade of
hernia-related complications in each patient. Secondary end-
points were the cumulative hernia recurrence rate, pain, and
quality of life.
Statistical analysis
The sample size was determined at 100 patients. This calcu-
lation was based on χ2 tests with α = 0.05, power of 90%, and
an expected decrease in overall complication rate at 2 years
from 50 to 15% due to elective repair of the umbilical hernia
[8]. This requires 42 patients per treatment arm, 50 when
accounting for a 20% loss to follow-up.
All patients were analyzed in the group randomized to (in-
tention-to-treat). For the primary outcome—cumulative com-
plication rate of the umbilical hernia in the two study arms—
Kaplan-Meier curves were constructed and compared with the
log-rank test. The maximal observed LHCR grade was com-
pared with the χ2 test, and secondary outcomes were analyzed
through linear mixed effect models, correcting for time,
randomization group, gender, time to complication, and time
to liver transplantation.
Statistical analysis was performed using R statistical soft-
ware (version 3.3.1). This trial is registered at Clinicaltrials.
gov; number NTC01421550.
Results
Due to unforeseen circumstances, the study was ended prema-
turely. Between February 2011 and July 2014, 34 patients
were randomly assigned to either the intervention group (n =
16) or the conservative group (n = 18). Baseline characteristics
are shown in Table 2. The median time of follow-up was 19.5
months (range 0 to 33.7 months).
Twenty-four-month morbidity
Eight patients (44.4%) in the conservative group received um-
bilical hernia repair: five received liver transplantation with
simultaneous repair of the umbilical hernia, and three patients
had elective or emergency repair due to complaints or incar-
ceration. Of these eight patients, three developed recurrence of
Table 1 The National Surgical Complication Registry (“Landelijke
Heelkundige Complicatie Registratie” (LHCR)) score
Grade Description of complication
0 No health disadvantage, no real complication
1 Temporary health disadvantage, recovery without reoperation
2 Recovery after (re)operation
3 (Likely) permanent damage or invalidity
4 Death
Table 2 Baseline characteristics
Intervention (n = 16) Wait-and-see (n = 18)
Gender (male, %) 11 68.8% 15 83.3%
Agea 57 48.8–61.5 58 56.0–60.8
BMIa 25.8 23.5–29.4 22.6 21.7–26.8
MELD scoreb 15.5 4.7 16.3 4.5
Hernia widthb 2.68 2.5 1.94 1.1
Smoking 11 68.8% 6 33.3%
COPD 1 6.3% 2 11.1%
Diabetes 6 37.5% 4 22.2%
Liver failure cause
Alcoholic hepatitis 11 68.8% 8 44.4%
PSC 1 6.3% 3 16.7%
PBC 1 6.3% 0 0%
Hepatitis B 0 0% 1 5.6%
Hepatitis C 2 12.5% 2 11.1%
Autoimmune 1 6.3% 0 0%
NASH 0 0% 2 11.1%
Other 0 0% 2 11.1%
Numbers are given in n (%)
aMedian (interquartile range)
bMean (standard deviation)
BMI, body mass index;MELD, model of end-stage liver disease; COPD,
chronic obstructive pulmonary disease; PSC, primary sclerosing
cholangitis; PBC, primary biliary cholangitis; NASH, non-alcoholic
steatohepatitis
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the umbilical hernia (16.7%). In the intervention group, only
one patient had a recurrence of the umbilical hernia (6.3%).
The mean length of stay after umbilical hernia repair was 3.21
days (range 1 to 9 days).
With regard to 24-month morbidity, 22 patients (64.7%)
had at least one hernia-related complication, totaling 40
events. In the intervention group, eight patients (50%) experi-
enced 18 events. In the wait-and-see group, 14 patients (78%)
had 22 events.
In Table 3, the complications are split up for minor
and major complications. Figure 1 is a Kaplan-Meier
depiction of the time to first event per study arm. No
difference between groups was found in time to the first
event (p = 0.663). From Table 3, the difference in mor-
tality between groups seems rather large, yet no statisti-
cal difference was found (p = 0.0682). The survival is
also graphically depicted in Fig. 2. In the intervention
group, one death occurred due to the development of
spontaneous bacterial peritonitis resulting in multi-organ
failure 1 week after surgery, the other death was due to
the progression of end-stage malignant disease. In the
wait-and-see group, mortality was due to subcapsular
bleeding af ter the placement of a transjugular
intrahepatic portosystemic shunt in one patient; the other
causes were the progression of liver disease, end-stage
malignant disease, and non-surgery-related pneumonia.
Additionally, no statistical significance was observed be-
tween the LHCR grades in the two groups (p = 0.152).
When stratified for MELD score, more complications in
total (n = 24 and n = 16, respectively) and more severe com-
plications (n = 20 and n = 13, respectively) can be found in the
group with patients having a score > 15, compared to the
patient group with MELD score ≤ 15.
Secondary outcomes
With regard to the quality of life measured through the SF-36,
the coefficients in the linear mixed model show that over time
both the physical component score (PCS) and mental compo-
nent score (MCS) increase for the intervention group, com-
pared to a much smaller increase in the PCS and even a de-
crease in the MCS for the conservatively treated group (as
shown by the negative coefficient for the interaction
between the time and randomization group in Table 4). The
Table 3 Number of patients with
complications, total number of
complications, and maximum
LHCR grade in patients with
complications after 24 months
Total (n = 34) Intervention (n = 16) Conservative (n = 18)
Patients with complication (%) 22 (64.7) 8 (50) 14 (77.8)
1 complication (%) 13 (38.2) 4 (25) 9 (50)
> 1 complication (%) 9 (26.5) 4 (25) 5 (27.8)
Total complications 40 18 22
Minor 7 3 4
SSI superficial/deep 3 1 2
Seroma 1 0 1
Hematoma 2 2 0
UTI 1 0 1
Major 33 15 18
Organ space SSI 1 1 0
Incarceration 7 3 4
Necrosis of the skin 1 1 0
Post-op. leakage 2 2 0
Bacterial peritonitis 1 1 0
Decompens. Cirr. 6 2 4
Unexp. ICU adm. 5 3 2
Death 10 2 8
Maximum LHCR grade
1 6 4 2
2 5 2 3
3 1 0 1
4 10 2 8
SSI, surgical site infection; UTI, urinary tract infection; Post-op., postoperative; cirr, cirrhosis; Unexp. ICU adm,
unexpected intensive care unit admission; LHCR, Landelijke Heelkundige Complicatie Registratie (National
Surgical Complication Registry)
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model further reveals that liver transplantation causes patients
to score higher on both component scores. Additionally, fe-
male patients appear to have a higher MCS than their male
counterparts.
Quality of life measured through the EQ-5D questionnaire
showed results similar to the SF-36 questionnaire. The created
model showed that over time, quality of life increased (coef-
ficient time 0.64, 95% CI 0.02–1.27). This increase was, how-
ever, smaller for the conservative group compared to the in-
tervention group, shown by a negative coefficient (coefficient
time:wait-and-see − 0.32, 95% CI − 1.33–0.69). Quality of
life was at baseline already higher in the intervention group.
For pain outcomes, the coefficients in the created model
show that pain decreases irrespective of the randomization
group over time (coefficient time − 0.45, 95% CI − 0.99–
0.09). At baseline, the scores were higher for women (coeffi-
cient 5.85, 95% CI − 12.59–24.29), and for patients in the
wait-and-see group (coefficient wait-and-see 25.99, 95% CI
8.68–43.32).
Unfortunately, no cost-effectiveness analysis was per-
formed due to the early termination of the study.
Discussion
In this study, equal numbers of hernia-related complications
were observed for elective operation and conservative ap-
proach. Additionally, elective repair and wait-and-see treat-
ment were associated with similar quality of life and pain
scores. Though underpowered, this suggests that elective re-
pair is safe in patients with liver cirrhosis and can be per-
formed when the patient experiences complaints from his/
her umbilical hernia.
In the current study, complication rates were high in both
study arms. This is in line with expectations considering the
high average MELD score observed in the patient group, as a
higher MELD score is associated with higher perioperative
morbidity and mortality in various types of elective proce-
dures [17–22]. In the current study, patients with a MELD
score ≥ 15 experienced more incarceration, skin necrosis,
and unexpected ICU admission, and had a higher mortality
rate. Despite the high numbers of complications, this study
shows that even in patients with a relatively high MELD
score, elective repair of the umbilical hernia is safe.
Additionally, a conservative approach can also be accompa-
nied by severe complications; our study showed more incar-
ceration, decompensated cirrhosis, and ultimately death for
the patients in the conservative treatment group than in the
intervention group. Other authors describe a nearly 23% emer-
gency surgery rate due to complications of a hernia during
conservative treatment [23].
The most common cause of liver failure in our study
was alcoholic liver cirrhosis. Alcoholic liver cirrhosis can
cause large amounts of ascites [24], which is associated
with complications, including umbilical hernia [25]. This
association is applicable for both groups: a large amount
of ascites can cause spontaneous bacterial peritonitis in
both groups [26], more frequent incarceration and wound
problems in the wait-and-see group [8, 27, 28], and more
recurrence and postoperative leakage of ascites in the in-
tervention group [28–30].
However, the results from our study need to be
interpreted with caution. The major limitation of this study
is the small patient group, due to the premature stop of the
study. As a consequence, limited data were available for
modeling the secondary outcomes, resulting in large con-
fidence intervals. Especially at later time points, many pa-
tients had dropped out of the study due to death or other
causes; this was however balanced between the two ran-
domization groups.
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Another consequence of the small patient group is the
chance for clustering of confounders in the randomization
process. This could have caused the difference already present
at baseline for quality of life and VAS scores. However, these
differences could also have been due to the fact that patients
were not blinded for the randomization group they were in.
The fact that patients knew they would receive an operation to
relieve them of their umbilical hernia might have influenced
how those patients filled out their quality of life forms.
Nonetheless, the effect of the baseline differences on the sec-
ondary outcomes is more than marginal and necessitates care-
ful consideration.
Despite the premature stop of patient inclusion, this study
remains a methodologically well-performed randomized con-
trolled trial, providing a higher level of evidence than small,
retrospective cohorts with their inherent bias. Therefore—
unfortunately not providing a definite answer to the manage-
ment of umbilical hernias in patients with cirrhosis and
ascites—this study is a valuable addition to the current body
of knowledge on this subject and contributes to providing
transparency to the scientific community. In the context of
scientific integrity, this data can prove valuable in future me-
ta-analyses, and refraining from reporting the data adds to the
burden of publication bias.
Conclusion and implications
Despite not having enough power to show a significant differ-
ence between the two groups, this randomized controlled trial
suggests that elective repair of an umbilical hernia does not
cause excessive morbidity in cirrhotic patients—even with high
MELD scores—and is thus advisable when the patient experi-
ences complaints of the umbilical hernia. Considering this fact,
one could argue that early elective repair when MELD scores
are low—even in patients on the waiting list for
transplantation—is the safer strategy. The definitive answer to
whether elective umbilical hernia repair causes significantly less
complications than watchful waiting in patients with liver cir-
rhosis remains unknown, which leaves room for further study.
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Table 4 Coefficients from the
created linear mixed models for
quality of life expressed through
the physical and mental
component score, with their
respective 95% confidence
intervals
PCS MCS
Value 95% CI Value 95% CI
(Intercept) 35.70 29.79–41.60 42.46 37.69–47.23
Time 0.34 0.09–0.59 0.32 − 0.01–0.65
Wait-and-see group − 9.08 − 16.45 to − 1.72 − 3.63 − 9.61–2.34
Event at timepoint 0.44 − 0.74–1.61 0.06 − 1.44–1.55
LTx at timepoint 5.39 0.59–10.20 0.37 − 5.40–6.13
Female 2.27 − 5.61–10.16 8.66 3.06–14.27
Time:wait-and-see − 0.25 − 0.66–0.15 − 0.54 − 1.05 to − 0.03
PCS, physical component score; MCS, mental component score; CI, confidence interval; LTx, liver
transplantation
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